Scott Philibin
About Scott Philibin
Scott Philibin is a Senior Medical Science Liaison at Alkermes with over 15 years of experience in medical science liaison and research, specializing in psychopharmacology of schizophrenia, substance use, and negative affective disorders.
Title
Scott Philibin is a Senior Medical Science Liaison currently employed at Alkermes. He has been serving in this role since June 2017.
Professional Experience at Alkermes
Scott Philibin has been with Alkermes since June 2017, holding the position of Senior Medical Science Liaison. In this role, he is involved in providing medical and scientific support, focusing on areas such as schizophrenia, substance use, and negative affective disorders. His responsibilities encompass scientific exchange, providing insights to internal teams, and facilitating relationships with key opinion leaders in the field.
Previous Roles at Lundbeck
Prior to his current position at Alkermes, Scott Philibin worked at Lundbeck as a Medical Science Liaison from 2015 to 2017. He held this role for two years, engaging in various tasks related to medical and scientific communications within the company, with a focus on psychiatric and neurological disorders.
Research Experience at University of Texas Southwestern Medical Center
Scott Philibin spent six years as a Research Associate at the University of Texas Southwestern Medical Center from 2009 to 2015. During this time, he conducted significant research on psychiatric disorders, contributing to the academic and scientific community with his findings and insights.
Academic Background in Biopsychology
Scott Philibin holds a Ph.D. in Biopsychology from Virginia Commonwealth University, where he studied from 2000 to 2006. His doctoral research focused on the psychopharmacology of schizophrenia, substance use, and negative affective disorders. His strong academic background laid the foundation for his extensive career in medical science and research.